As 2024 is nearing its end, investors with a time machine are looking to visit December 2023 and take their long positions in ...

With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.

Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...

A Fremont pharmaceutical company received an investment of approximately $50 million — about $3.56 per share — in a private ...

Discover the top and bottom performers of the Nasdaq-100 in 2024, along with their Seeking Alpha quant ratings.

This study provides important insights into the regulation of a retained intron in the mRNA coding for OGT, a process known to be regulated by the O-GlcNAc cycling system, and highlights the ...

Researchers discovered that the mRNA modification m6A triggers rapid degradation, regulating protein production. This ...

A University of Arkansas for Medical Sciences (UAMS) research team has been awarded a $3 million grant from the National ...

Scientists have has pioneered antivirals targeting viral methyltransferases, offering a new strategy for treating RNA and DNA ...

The Centers for Disease Control and Prevention called it the first severe case in the U.S., though the risk to most of the public is still low.

A new type of norovirus is causing a very high number of cases in countries like England, just as a large trial of an mRNA ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 10.82% ...